Remix Therapeutics said it received positive preliminary results for the ongoing Phase 1 of its lead drug, REM-422, in ...

Biogen will pay a Chicago biotech $70 million upfront, plus up to $990 million in milestone payments, for an early-stage ...

A lector, a once-high-flying Bay Area biotech company that researches treatments for degenerative brain disorders like ...

Join us as we dissect Summit Therapeutics' potential in the biotech sector. Can their promising drug Ansuvimab overcome the ...

In the past week or so, a gold and silver miner, a struggling offshore driller, and a biotech saw some huge insider buying.

Swiss investment company BB Biotech reported an outstanding third quarter in 2025. Here’s why.

The other is a top REIT that cranks out a dividend far more often than the usual U.S. business. It isn't all that difficult ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by ...

Intensity Therapeutics Inc., a clinical-stage biotechnology company based in Shelton, announced this week that its ...

Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...

BioNEST Incubator launches at Kathua Biotech Park to support innovators, agri-entrepreneurs, and startups in J&K and ...

The September data gives the Fed a clear path for widely expected rate cuts heading into their remaining meetings this year.